Publication committees in clinical trials in headache

Cephalalgia

Volumn 32, Issue 1, 2012, Pages 86-

  Tfelt Hansen, Peer Carsten ^a   Olesen, Jes ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

NARATRIPTAN; TRIPTAN DERIVATIVE;

CLINICAL TRIAL; HEADACHE; HUMAN; LETTER; MIGRAINE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

EUROPE; HEADACHE; HUMANS; MULTICENTER STUDIES AS TOPIC; PUBLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84856245412     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102411430849     Document Type: Letter

References (6)

1. Tfelt-Hansen P. Unpublished clinical trials with sumatriptan. Lancet. 2009 ; 374: 1501-1502
2. Tfelt-Hansen PC. Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register. J Headache Pain. 2011 ; 12: 399-403
3. Mathew NT, Schoenen J, Winner P, et al. Comparative efficacy of eletriptan versus sumatriptan 100 mg. Headache. 2003 ; 43: 214-222 (Pubitemid 36348767)
4. Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA. 2007 ; 297: 1443-1454 (Pubitemid 46556470)
5. GlaxoSmithKline. Clinical Study Register, www.gsk-clinicalstudyregister. com (2011, accessed 15 November 2011).
6. Johnson RT, Dickersin K. Publication bias against negative results from clinical trials: three of the seven deadly sins. Nat Clin Pract Neurol. 2007 ; 3: 590-591 (Pubitemid 350048220)